Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Expanded Recommendations for OBRONA

24 Jul 2024 07:00

RNS Number : 5304X
Plant Health Care PLC
24 July 2024
 

24 July 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Expanded Recommendations to Support Commercial Sales of OBRONA® Biochemical Fungicide for Use on Corn, Soybean, and Wheat

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce the issuance of new recommendations for use of OBRONA® biochemical fungicide to provide farmers with another tool to control a wide range of diseases and improve crop yield and harvest quality in corn, soybean and wheat in key US states.

 

Highlights:

- The new Section 2(ee) recommendations cover the use of OBRONA to control diseases in the following crops:

· Control in corn of common rust, gray leaf spot, northern and southern corn leaf blight and tar spot,

· Control in soybean of downy mildew, frogeye leaf spot, sclerotinia stem rot, and white mold,

· Control in wheat of multiple rust species: black, leaf, stem, stripe, and yellow rust. 

- These diseases represent serious threats to agricultural production and can significantly reduce crop yields, harvest quality, and grower profitability if not properly managed. OBRONA provides growers with a novel mode of action and an environmentally friendly tool to control these diseases and support sustainable agriculture based on reduced reliance on established synthetic pesticides. 

 

Section 2(ee) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) allows users to apply pesticides under certain limited conditions that are not specified on the commercial label. The recommendations shown above have been written to address control of target pests not listed on the OBRONA label.

 

Compared to current biocontrol products, OBRONA provides highly consistent and convenient product performance to control a broad spectrum of fungal and bacterial plant diseases. In addition to providing growers with a favorable return on investment, OBRONA brings growers convenience as it is compatible with many commonly used fungicides, herbicides, and insecticides in tank-mix and sequential application programs. OBRONA has no special requirements for storing or handling, which allows greater flexibility within the distribution channel and ease of on-farm application.

  

Jeff Tweedy, CEO of Plant Health Care, said: ‟Wilbur-Ellis is aggressively launching OBRONA this summer across the mid-west for disease control in corn, soybean and wheat. Results from field testing of OBRONA are very promising and we are excited to continue working with Wilbur-Ellis to bring the benefits of OBRONA to a wide range of growers across the country for the 2024 season."

 

  

# # #

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

 

 

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

 

Tel: +44 (0) 131 220 9771

 

 

For further information about Wilbur-Ellis, please contact: Jeanne Forbis, jforbis@wilburellis.com

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com

Wilbur-Ellis Agriculture, with annual sales revenue of $2.5 billion, has over 150 retail locations throughout the U.S.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAQKNBKABKDQOB
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.